Document is current
Any future updates will be listed below
-
Authors
Hayashi, Takaaki http://orcid.org/0000-0002-1535-0279
Mizobuchi, Kei http://orcid.org/0000-0001-5389-6507
Kameya, Shuhei
Ueno, Shinji
Matsuura, Tomokazu
Nakano, Tadashi
-
Funding
Funding for this research was provided by:
Grants-in-Aid for Scientific Research (21K09756)
Alcon
AMO
Daiichi-Sankyo
Chugai Pharmaceutical
Mitsubishi Tanabe Pharma Corporation
Senju
Bayer
Ritz medical
Uni-hite
Kuribara
- License Information
-
More Information
Article History
Received: 5 May 2022
Accepted: 4 May 2023
First Online: 25 May 2023
Declarations
:
: Takaaki Hayashi received research funds from Alcon (Tokyo, Japan), Johnson and Johnson Vision, AMO (Tokyo, Japan), Daiichi Sankyo (Tokyo, Japan), Chugai (Tokyo, Japan), Mitsubishi Tanabe Pharma (Osaka, Japan), Senju (Osaka, Japan), Bayer (Osaka, Japan), Ritz medical (Aichi, Japan), Uni-hite (Kanagawa, Japan), and Kuribara (Gunma, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: This article does not contain any studies with animals performed by any of the authors.
: The patient provided informed consent for publishing this report.
